COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION RENAL DENERVATION THERAPY DEVICES: THRESHOLD ANALYSIS AND PROJECTIONS OF THE SPYRAL HTN-ON MED TRIAL FOR GERMANY
Pietzsch JB, Geisler BP, Schmieder R (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: ELSEVIER SCIENCE INC
City/Town: NEW YORK
Pages Range: S261-S261
Conference Proceedings Title: VALUE IN HEALTH
DOI: 10.1016/j.jval.2018.09.1556
Authors with CRIS profile
Involved external institutions
United States (USA) (US)How to cite
APA:
Pietzsch, J.B., Geisler, B.P., & Schmieder, R. (2018). COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION RENAL DENERVATION THERAPY DEVICES: THRESHOLD ANALYSIS AND PROJECTIONS OF THE SPYRAL HTN-ON MED TRIAL FOR GERMANY. In VALUE IN HEALTH (pp. S261-S261). NEW YORK: ELSEVIER SCIENCE INC.
MLA:
Pietzsch, J. B., B. P. Geisler, and Roland Schmieder. "COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION RENAL DENERVATION THERAPY DEVICES: THRESHOLD ANALYSIS AND PROJECTIONS OF THE SPYRAL HTN-ON MED TRIAL FOR GERMANY." Proceedings of the VALUE IN HEALTH NEW YORK: ELSEVIER SCIENCE INC, 2018. S261-S261.
BibTeX: Download